Volunteer Donate Get Help
 

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

FDA Approval for New Precision Medicine

Published: July 20, 2018

Source: Leukemia & Lymphoma Society

Progress in treating acute myeloid leukemia (AML), a blood cancer that takes more than 10,000 lives in the United States each year, took an important step forward today with the U.S. Food Drug Administration ... More >>.


Clinical Stages May Predict Outcomes in CLL

Published: July 20, 2018

Author: James Nam, PharmD

Source: Cancer Therapy Advisor

Determining the clinical stage of patients with chronic lymphocytic leukemia (CLL) may be an effective prognostic marker for time to next therapy (TTNT) and overall survival (OS), according to a study publis ... More >>.


Factors Associated With AML

Published: July 09, 2018

Author: Randi Hernandez

Source: Cancer Therapy Advisor

Using deep sequencing techniques, investigators of a study published in Nature determined they were able to tease out the predictors that are associated with the development of acute myeloid leukemi ... More >>.


Researchers Develop Synthetic T-Cells

Published: June 27, 2018

Source: Unversity of Califonia - Los Angeles

UCLA researchers have developed synthetic T lymphocytes, or T cells, that are near-perfect facsimiles of human T cells. The ability to create the artificial cells could be a key step toward more effective dr ... More >>.


Remission in CML After 96 Weeks

Published: June 25, 2018

Author: Alexander M. Castellino, PhD

Source: Cancer Therapy Advisor

A long-term follow-up of the ENEST freedom study reported that 96 weeks after stopping treatment, nearly half (48.9%) of patients with chronic myeloid leukemia (CML) with front-line treatment with nilotinib ... More >>.


Identifying Genetic Subtypes

Published: May 30, 2018

Author: Susan Jenks

Source: Lymphoma Advisor

Researchers' identification of four new genetic subtypes in the most common lymphomas could move treatments closer to true "precision" medicine in the future, experts say.

Although the recent finding ... More >>.


Life-Long Considerations With TKI Therapy

Published: May 22, 2018

Author: Andrea S. Blevins Primeau, PhD, MBA

Source: Cancer Therapy Advisor

There is no established standard treatment protocol for pediatric chronic myeloid leukemia (CML) and many questions remain regarding long-term outcomes with tyrosine kinase inhibitor (TKI) therapy.

P ... More >>.


Likely Cause of Childhood Leukemia

Published: May 21, 2018

Source: Institute of Cancer Research

A major new analysis reveals for the first time the likely cause of most cases of childhood leukemia, following more than a century of controversy about its origins. Professor Mel Greaves from The Institute ... More >>.


PET Scans Predict Survival Outcomes

Published: May 14, 2018

Author: James Nam, PharmD

Source: Cancer Therapy Advisor

Interim positron-emission tomography (PET) may predict survival, but intensifying treatment based on PET may not improve therapeutic outcomes among patients with aggressive non-Hodgkin lymphoma (NHL), accord ... More >>.


Long-term Survival Improving

Published: May 10, 2018

Author: James Nam, PharmD

Source: Oncology Nurse Advisor

Improvements in the US healthcare system has led to increases of survival among patients with advanced Hodgkin Lymphoma over 3 decades, according to a study in The Oncologist.

Altho ... More >>.


©2015 Stephanie Robinson Foundation | Privacy Policy